*/
The Bar Standards Board (BSB) has abandoned the controversial quality assurance scheme for advocates (QASA).
After six years, several delays and consultations and an unsuccessful judicial review by the profession, the BSB finally announced that it will not implement QASA.
Following a review, the BSB said it has decided to take a new approach in line with its risk and evidence based regulatory regime, which encourages barristers to take greater responsibility for their own learning and development.
BSB Chair, Sir Andrew Burns, said: ‘This in no way should be seen as a reduction in the BSB’s commitment to ensure that the public has access to good quality barristers. It is rather a reflection of our willingness to adapt and change our regulatory approach so as best to deliver our strategic objectives.’
Welcoming the decision, Bar Chair, Andrew Langdon QC, said: ‘The birth of the Quality Assurance Scheme for Advocates was not celebrated by many and its death will be mourned by fewer.’
He said: ‘It is well known that many barristers were unhappy with the proposed scheme, not least because it risked placing both advocates and judges in a problematic position, given their respective roles during a trial.
‘Similarly, the Bar does not recognise that the concept of a “plea only advocate” was compatible with the role of defence counsel.’
QASA’s demise, Langdon said, allows space for the Bar itself, including through the work of each of the Bar Council, the Inns, the College of Advocacy, the Circuits and the specialist Bar associations, to reinforce standards in a more flexible and proportionate way.
The Bar Standards Board (BSB) has abandoned the controversial quality assurance scheme for advocates (QASA).
After six years, several delays and consultations and an unsuccessful judicial review by the profession, the BSB finally announced that it will not implement QASA.
Following a review, the BSB said it has decided to take a new approach in line with its risk and evidence based regulatory regime, which encourages barristers to take greater responsibility for their own learning and development.
BSB Chair, Sir Andrew Burns, said: ‘This in no way should be seen as a reduction in the BSB’s commitment to ensure that the public has access to good quality barristers. It is rather a reflection of our willingness to adapt and change our regulatory approach so as best to deliver our strategic objectives.’
Welcoming the decision, Bar Chair, Andrew Langdon QC, said: ‘The birth of the Quality Assurance Scheme for Advocates was not celebrated by many and its death will be mourned by fewer.’
He said: ‘It is well known that many barristers were unhappy with the proposed scheme, not least because it risked placing both advocates and judges in a problematic position, given their respective roles during a trial.
‘Similarly, the Bar does not recognise that the concept of a “plea only advocate” was compatible with the role of defence counsel.’
QASA’s demise, Langdon said, allows space for the Bar itself, including through the work of each of the Bar Council, the Inns, the College of Advocacy, the Circuits and the specialist Bar associations, to reinforce standards in a more flexible and proportionate way.
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Developing a tech start-up demands a different definition of excellence to the Bar, says Saara Idelbi. The co-creator of Advocatr on entrepreneurship, AI advocacy training, and matching the thrill of a killer cross-examination
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC
